The Editorial Executive Committee welcomes letters, which should be less than 250 words. Before a decision to publish is made, letters which refer to a published article may be sent to the author for a response. Any letter may be sent to an expert for comment. When letters are published, they are usually accompanied in the same issue by their responses or comments. The Committee screens out discourteous, inaccurate or libellous statements. The letters are sub-edited before publication. Authors are required to declare any conflicts of interest. The Committee's decision on publication is final.
Letter to the Editor
Given what we know about the effects of conflicts with the pharmaceutical industry and medical practice, it is simply no longer acceptable to have significant conflicts of interest and provide meaningful information on the benefits and harms of medicines, especially psychiatric medicines. There is a scholarly review of this issue by the co-founder of the Cochrane Collaboration and co-author of the CONSORT guidelines.1
Some articles in Australian Prescriber are written by authors who have received payments from the pharmaceutical industry. Your publication – and NPS MedicineWise – risks losing its stature if it continues publishing reviews by extensively conflicted authors.